Company Overview
The addition of the Oncogene Science’s ELISA product line to WILEX, with a combined focus to advance oncology research and patient care, further enhances our mission to deliver companion diagnostic biomarker tests for targeted therapies. WILEX Inc. will continue to develop a wide range of tests to measure oncogenes, growth factors and growth factor receptors as well as markers of metastasis, angiogenesis, hypoxia and apoptosis. Under the strong leadership of WILEX, we look forward to continued success with our focus on the manufacturing, marketing and sales of diagnostic assays developed to existing and new customers in the pharmaceutical and reference laboratory industries
| WILEX Inc. Oncogene Science 100 Acorn Park Drive Cambridge, MA 02140 USA |
 |
read: 1102 | today: 5